by McDermott + Bull | Nov 7, 2024 | Ken Dropiewski, Healthcare + Life Sciences, Healthcare + Life Sciences Placement Announcement, Ken Dropiewski Placement Announcement, Michael Matranga, Placement Announcement
McDermott + Bull has successfully placed Lisa Henry as Vice President, Clinical and Regulatory at Magenta Medical. Reporting to the CEO, Lisa will lead the clinical and regulatory strategies critical to Magenta’s success. As the first U.S.-based team member, Lisa will...
by McDermott + Bull | Sep 18, 2024 | Chris Bull, Anne Terry, Chris Bull Placement Announcement, Healthcare + Life Sciences, Healthcare + Life Sciences Placement Announcement, Ken Dropiewski, Ken Dropiewski Placement Announcement, Michael Matranga, Placement Announcement
McDermott + Bull has successfully placed Hussain Rangwala as Chief Technology Officer at Inari Medical. Reporting to the CEO, Hussain will drive the development and execution of innovative R&D strategies, including fostering a culture of innovation, ensuring...
by McDermott + Bull | Sep 10, 2024 | Healthcare + Life Sciences, Healthcare + Life Sciences Placement Announcement, Ken Dropiewski, Ken Dropiewski Placement Announcement, Paul Gibbons, Paul Gibbons Placement Announcement, Placement Announcement
McDermott + Bull has successfully placed Helen Routh and Beverly Huss as members of the Board of Directors at Clarius Mobile Health. They will bring their vast expertise in healthcare technology and medical devices to help Clarius continue to innovate and grow. Their...
by McDermott + Bull | Jun 25, 2024 | Investor Insights, Ken Dropiewski, Video
McDermott + Bull Partner Ken Dropiewski sits down with Catalyst Health Ventures Managing Partner Darshana Zaveri to discuss several key topics relevant to CEOs and investors alike. Darshana shares insights on how CEOs can best prepare for a productive meeting with...
by McDermott + Bull | Jun 25, 2024 | Healthcare + Life Sciences, Healthcare + Life Sciences Article, Ken Dropiewski, Ken Dropiewski Article, Technology Article
The JPM Q1 2024 MedTech Licensing and Venture report highlights the first quarter of 2024 and shows promising developments in the MedTech investment landscape. There are indications of a potential recovery and growth compared to previous years. Can we be so lucky?...
by McDermott + Bull | May 31, 2024 | Healthcare + Life Sciences, Healthcare + Life Sciences Placement Announcement, Ken Dropiewski, Ken Dropiewski Placement Announcement, Michael Matranga, Placement Announcement
McDermott + Bull has successfully placed Tom Mock as the Director of Research and Development at NVMedTech. Tom will oversee the completion of one of the company’s main intravascular products, managing its design finalization, initiating GLP animal studies, and...
